ALFUZOSIN HYDROCHLORIDE (alfuzosin hydrochloride) by Wockhardt is post-synaptic alpha 1 -adrenoreceptors, which are located in the prostate, bladder base, bladder neck, prostatic capsule, and prostatic urethra. Approved for signs, symptoms of benign prostatic hyperplasia, hypertension. First approved in 2011.
Drug data last refreshed 20h ago
post-synaptic alpha 1 -adrenoreceptors, which are located in the prostate, bladder base, bladder neck, prostatic capsule, and prostatic urethra.
Worked on ALFUZOSIN HYDROCHLORIDE at Wockhardt? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.